According to "Adjustment of chromatographic condition" described in the 8th edition of the European Pharmacopoeia (EP), parameters in TLC, LC, GC and SFC may be adjusted without revalidation provided that the system suitability requirements are satisfied. For example, reduction in column particle size by 50% is within the permitted range for isocratic elution.
This article introduces an example wherein high speed analysis of pharmaceuticals and related substances was newly developed in compliance with the EP, using the Nexera-i MT integrated high performance liquid chromatograph. Since the Nexera-i MT integrates both HPLC and UHPLC flow lines, it allows method modification to be conducted in a single system, and the new method may be adopted without transferring it to a new system, thus minimizing the work required improving productivity.
To download your copy of this application note complete the form opposite.
Eclipse Business Media Ltd, Regd in England, No. 06513189, Woodview, Bull Lane Industrial Estate, Sudbury, CO10 0FD, United Kingdom, T +44 (0)161 818 7434, info@sepscience.com
Eclipse Business Media Ltd needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy or contact privacy@labxmediagroup.com
Copyright © 2023. All rights reserved